Ready to feel lighter and bloatfree
10.1177/1759720X21998279
As its predicted GLP-1 use will continue to rise in OSA patients, a common topic in discussions, according to Peters, is how GLP-1s might affect the use of other sleep apnea therapies, like CPAP, oral appliances, and hypoglossal nerve stimulation
10.3390/polym12010094 [DOI] [PMC free article] [PubMed] [Google Scholar] 254.Saeed A, et al
Introduction The gluco-regulatory actions of the glucagon-like peptide-1 (GLP-1) and its related therapeutic mimetics include enhancement of glucose-dependent insulin secretion and suppression of glucagon release from pancreatic islets, as well as a decrease in postprandial glucose excursion by delay of gastric emptying and centrally-mediated effects on satiety and energy metabolism [1], [2]
This significant price difference makes long-term use more accessible for many people, especially those paying out of pocket